Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine in Bipolar II Depression
NCT00274677Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2003
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lamotrigine in Bipolar II disorder (BP-II), sponsored by GSK. Started Nov 2003; status: completed.
02
Drugs
lamotrigine
03
Conditions
Bipolar II disorder (BP-II)
Beyond the preview
Go deeper on NCT00274677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274677.